The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A novel plasma amino acid profile-based biomarker for early detection of ovarian cancer.
E. Miyagi
Research Funding - Ajinomoto
R. Numazaki
Research Funding - Ajinomoto
Y. Ihata
Research Funding - Ajinomoto
T. Muramatsu
Employment or Leadership Position - Ajinomoto
Research Funding - Ajinomoto
A. Imaizumi
Employment or Leadership Position - Ajinomoto
Stock Ownership - Ajinomoto
Research Funding - Ajinomoto
H. Yamamoto
Employment or Leadership Position - Ajinomoto
Stock Ownership - Ajinomoto
Research Funding - Ajinomoto
M. Yamakado
Consultant or Advisory Role - Ajinomoto
Research Funding - Ajinomoto
N. Okamoto
Consultant or Advisory Role - Ajinomoto
M. Asai-Sato
Research Funding - Ajinomoto
F. Hirahara
Research Funding - Ajinomoto